Sign in

CIK 0001570562

  • Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461385614
Phone
+1 949-284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. 4 Grant or award MOATAZEDI DAVID acquired 214,286 shares (grant or award)
  2. 4 Grant or award SILVERNAIL LAUREN P acquired 53,571 shares (grant or award)
  3. 4 Grant or award Avelar Rui acquired 53,571 shares (grant or award)
  4. 4 Grant or award Chief Marketing Officer acquired 50,000 shares (grant or award)
  5. 4 Grant or award Director acquired 15,568 shares (grant or award)
  6. 4 Grant or award Director acquired 15,568 shares (grant or award)
  7. 4 Grant or award Director acquired 15,568 shares (grant or award)
  8. 4 Grant or award Director acquired 15,568 shares (grant or award)
  9. 4 Grant or award Director acquired 15,568 shares (grant or award)
  10. 4 Grant or award Director acquired 15,568 shares (grant or award)
  11. 4 Grant or award Director acquired 36,508 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale 10% owner sold 2,597,475 shares at $9.50 ($24,676,013)
  14. 4 Open-market buy 10% owner bought 51,000 shares at $10.93 ($557,568)
  15. 4 Open-market buy 10% owner bought 110,000 shares at an average $11.06 ($1,216,791)
  16. 4 Open-market sale Director sold 26,077 shares at $11.00 ($286,722)
  17. 4 Open-market buy 10% owner bought 142,000 shares at an average $11.10 ($1,576,808)
  18. 4 Open-market buy 10% owner bought 103,000 shares at an average $10.53 ($1,084,808)
  19. 4 Open-market sale Director sold 61,840 shares at an average $10.59 ($654,871)
  20. 4 Open-market sale Director sold 67,083 shares at an average $10.20 ($684,561)

Page 7 of 13 · 252 filings